Join the ECHO webinar featuring Dr. Shreya Shukla (Co-Founder & Director of Research, Notch Therapeutics)!

Dr. Shukla’s presentation entitled, “Maximizing the Benefits of Cell Therapy by Developing T Cell Products from Renewable Induced Pluripotent Stem Cells”, will feature an overview of Notch Therapeutics, its technologies and the story behind its success.

Notch Therapeutics is developing a pipeline of cellular immunotherapies originating from pluripotent stem cells that are specifically engineered to address the underlying biology of complex disease systems.